Form 4: Hims & Hers CFO Sells Shares Under 10b5-1 Plan

Hims & Hers Health, Inc. CFO Oluyemi Okupe exercised stock options and subsequently sold 11,592 shares of Class A Common Stock for approximately $662,200 under a pre-arranged 10b5-1 trading plan.

Summary

• Oluyemi Okupe, Chief Financial Officer of Hims & Hers Health, Inc. (HIMS), reported transactions involving the company's Class A Common Stock.
• On October 17, 2025, Okupe exercised stock options to acquire 7,785 shares at an exercise price of $5.01 per share.
• On the same date, Okupe also exercised stock options to acquire an additional 3,807 shares at an exercise price of $11.53 per share.
• Immediately following these exercises, Okupe sold 11,592 shares of Class A Common Stock at an average weighted price of $57.1275 per share, totaling approximately $662,200.14.
• The sales were executed within a price range of $56.93 to $57.315 per share.
• All reported stock option exercises and sales were conducted pursuant to a Rule 10b5-1 trading plan adopted by Okupe on May 21, 2025.
• Following these transactions, Okupe beneficially owns 70,232 shares of Class A Common Stock directly.
• Okupe also holds 174,380 stock options with an exercise price of $5.01 and 56,169 stock options with an exercise price of $11.53, which remain unexercised.

Sentiment

Score: 5

Explanation: The transaction involves an insider sale, which can be perceived negatively. However, the sale was executed under a pre-arranged Rule 10b5-1 trading plan, indicating a scheduled disposition rather than an opportunistic one, which mitigates some of the negative sentiment. The exercise of options also implies the options were in-the-money, reflecting value.

Positives

• The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, which indicates an orderly and pre-scheduled disposition of shares rather than opportunistic selling.
• The exercise of stock options at lower prices ($5.01 and $11.53) demonstrates that the options were significantly in-the-money, reflecting value creation for the option holder.

Negatives

• The Chief Financial Officer sold a significant number of shares, which, despite being part of a 10b5-1 plan, could be interpreted by some investors as a signal of reduced confidence in the company's near-term stock price trajectory.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: May react to the insider sale, potentially influencing market perception and stock price, despite the pre-arranged nature of the transaction.

Next Steps

• Continued vesting of the remaining stock options held by the Chief Financial Officer, subject to service-based requirements.

Key Dates

Recommendation

The filing details a planned insider sale by the CFO, which, while executed under a 10b5-1 plan, could still be viewed cautiously by investors. Without broader financial context or additional company performance data, a 'hold' recommendation is prudent, advising investors to observe future company performance and any further insider activity.

Keywords

Hims & Hers Health, HIMS, Oluyemi Okupe, CFO, Insider Trading, Form 4, Stock Option Exercise, Share Sale, 10b5-1 Plan, Beneficial Ownership